• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Hospitals Investigate Start-Up Technologies for Superbug Disinfection

Article

We all go to the hospital to get well, but it’s also possible to catch something there. Each room in a hospital is exposed to a variety of bacteria, as patients with a laundry list of ailments come and go 365 days a year, turning such environments into a gladiator school for germs.

Hospital-acquired infections are said to cost the U.S. health-care system billions of dollars a year, and the country’s health insurers have grown tired of footing the bill. The Centers for Medicare & Medicaid Services has said 2012 will be the year that hospitals should start paying to treat infections contracted on their premises.

Read the full story: http://tinyurl.com/bp3989g

Source: The Wall Street Journal

Related Videos
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Jennifer Snow, MPA, NAMI
Jennifer Snow, MPA, NAMI
Dr Debra Patt
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life
Enrique Velazquez Villarreal, MD, PhD, MPH, MS, assistant professor in the department of integrative translational sciences at City of Hope
Dr Steven Manobianco
Related Content
Drug pricing | Image Credit: © TarikVision-stock.adobe.com

TrumpRx Launch Brings Savings—and Uncertainty

February 5th 2026
Article

First announced in September 2025, the online platform is set to offer access to prescription medications at steep discounts, with potential savings in the millions.

Read More

Managed Care Cast Square Image

The Orphan Drug Act in the Modern Drug Pricing Era

February 3rd 2026
Podcast

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

Insulin syringe | Image Credit: © ixel-Shot-stock.adobe.com

Express Scripts Avoids Fines but Agrees to Major Structural Overhaul

February 5th 2026
Article

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin.

Read More

managed care cast logo

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

January 27th 2026
Podcast

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

City St. George’s researcher Ateequllah Hayat, PhD, explains newly identified mechanisms behind lapatinib resistance in HER2-positive breast cancer.

New Molecular Drivers of HER2 Breast Cancer Resistance: A Q&A With Ateequllah Hayat, PhD

February 4th 2026
Article

Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.

Read More

Prescription drugs on a money banknotes. Concept of healthcare costs - Vitalii - stock.adobe.com.jpeg

Senate Democrats Outline Drug Pricing Agenda to Cut Patient Costs

February 4th 2026
Article

Finance Committee leaders propose expanding Medicare negotiation, curbing middlemen, and reinvesting in biomedical innovation as part of a 2026 health care affordability strategy.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.